Implementing Oregon’s Drug Policy, Wisconsin Wolf Hunt, Johnson & Johnson Vaccine. March 5, 2021, Part 1
Oregon Just Decriminalized Small Amounts of All Drugs. Now What?
On February 1, a big experiment began in Oregon: The state has decriminalized small amounts of all drugs, including heroin, cocaine, and methamphetamine. In the November election, voters passed ballot Measure 110 by a 16-point margin.
Now, if you’re caught with one or two grams of what some refer to as “hard drugs”, you won’t be charged. Instead, you’ll either pay a maximum $100 dollar fine, or complete a health assessment within 45 days at an addiction recovery center. This new system for services will be funded through the state’s marijuana tax.
But the measure is still controversial, and members of Oregon’s addiction and recovery community are split on if it’s a good idea. So how did we get here? Read and listen to the full story here.
Wisconsin Oversteps in Wolf Hunt
One of the final acts of the Trump Administration in late 2020 was to remove the gray wolf from the federal endangered species list. The U.S. Fish and Wildlife Service officially removed the species, which was once nearly extinct in the lower 48 states, in January. The wolves now number more than 6,000 in the northern Rockies and the western Great Lakes states.
In Wisconsin, a 2012 state law requires an annual wolf hunt when the animals are not under federal protection. State wildlife officials had begun planning for a hunt next November, but were forced by a lawsuit from an out-of-state hunting group to hold one before the end of February. That hunt lasted only three days before state officials shut it down: Licensed hunters killed 216 wolves in that time, more than 80 percent over the allowed quota of 119, and nearly 20 percent of the state’s estimated 1,000-plus wolves.
SciFri producer Christie Taylor talks to Wisconsin Public Radio reporter Danielle Kaeding and environmental science professor Adrian Treves about how hunters were able to kill so many wolves so fast—and what effect this year’s hunt might have on the health of wolf populations in the state.
What Does Johnson & Johnson’s Shot Mean for Our Vaccine Timeline?
The U.S. now has a third COVID-19 vaccine in our arsenal, as Johnson & Johnson’s shot got emergency approval last weekend. This one is different from the Pfizer and Moderna vaccines already in use: It’s only one dose, it’s inexpensive, and it doesn’t require very cold temperatures for storage. This means rural communities might get vaccinated faster, and our timeline to possible COVID-19 herd immunity could improve.
Scaling up vaccinations will be critical as the homegrown U.S. COVID-19 variants are taking hold. Variants from California and New York are becoming more widespread, though it doesn’t seem like we’ll need to change our strategy for fighting COVID-19 yet.
Ira is joined by Umair Irfan, staff writer at Vox, to talk about these stories and other big science news of the week.
Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Available Results
Generated results are saved to your library for reuse and search.
Choose Template
Pick the result you want. You can review provider and model before generating.
A concise first-pass summary for understanding the episode quickly.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
Repeatable methods, frameworks, mental models, processes, and systems.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Explicit actions, next steps, habits, recommendations, and things to avoid.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Scientific findings, mechanisms, studies, hypotheses, and the limits of the evidence discussed.
Technologies, AI models, technical methods, capabilities, limitations, and adoption implications.
Investment theses, assets, catalysts, valuation reasoning, time horizons, and risks.
Chronologies, actors, causes, consequences, turning points, and competing historical interpretations.
Policies, proposals, stakeholders, arguments, implementation constraints, and predicted effects.
Career paths, skills, hiring signals, workplace decisions, transitions, and limitations of the advice.
Behavioral mechanisms, biases, motivation, habits, emotions, interventions, and evidence limitations.
Economic mechanisms, incentives, indicators, market structure, forecasts, and uncertainty.
Leadership principles, team systems, organizational design, culture, feedback, and failure modes.
Audience, positioning, messaging, acquisition, retention, experiments, metrics, and failed approaches.
Teaching methods, learning strategies, practice, feedback, assessment, and effectiveness evidence.
Theses, premises, arguments, objections, values, thought experiments, and unresolved questions.
Communication patterns, conflict, boundaries, expectations, repair methods, and contextual limitations.
Books, papers, authors, courses, and other learning resources mentioned in the episode.
Repeatable methods, frameworks, mental models, processes, and systems.
Explicit actions, next steps, habits, recommendations, and things to avoid.
Memorable statements and important claims with attribution and source context.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.